Pharma Base India Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
- Paid Up Capital ₹ 39.60 Cr
- Company Age 26 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 10.00 Cr
- Revenue Growth 701.80%
- Profit Growth 2194.78%
- Ebitda 36.20%
- Net Worth 20.12%
- Total Assets -15.88%
About Pharma Base India
Pharma Base India Private Limited (PBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 1998 and has a history of 26 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 39.60 Cr.
The company has closed loans amounting to ₹10.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pharma Base India Private Limited India is Dhwani Punamiya as COMPANY SECRETARY. Kishor Parekh and Dhananjay Desai serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24200MH1998PTC115774
- Company No.
115774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 1998
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Pharma Base India Private Limited offer?
Pharma Base India Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Nutraceuticals & Dietary Supplements, Mineral Supplement, Vitamin Tablets & Capsules, Pharma Ingredients & Raw Materials, Nervous System and Antipsychotic API.
Who are the key members and board of directors at Pharma Base India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dhwani Punamiya | Company Secretary | 03-May-2024 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kishor Parekh | Director | 20-May-2019 | Current |
Dhananjay Desai | Director | 01-Aug-2020 | Current |
Financial Performance of Pharma Base India.
Pharma Base India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 701.8% increase. The company also saw a substantial improvement in profitability, with a 2194.78% increase in profit. The company's net worth Soared by an impressive increase of 20.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Base India?
In 2022, Pharma Base India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹10.00 Cr
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 10.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
22 Apr 2008 | Icici Bank Limited | ₹10.00 Cr | Satisfied |
How Many Employees Work at Pharma Base India?
Pharma Base India has a workforce of 3 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Base India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Base India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.